4-tert-Butyl-1-aza-cyclohexan-2,6-dion | 65970-74-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-tert-Butyl-1-aza-cyclohexan-2,6-dion
• 英文别名: 4-tert-butyl-piperidine-2,6-dione；4-Tert-butylpiperidine-2,6-dione
• CAS: 65970-74-3
• 化学式: C₉H₁₅NO₂
• 分子量: 169.224
• InChiKey: LBGGBHMZGDGSKP-UHFFFAOYSA-N

物化性质

• 沸点：
  295.1±9.0 °C(Predicted)
• 密度：
  1.046±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Resorcinol derivatives
  申请人：Sutter West Bay Hospitals

  公开号：US10202322B2

  公开（公告）日：2019-02-12

  The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.

  本公开涉及大麻素衍生物化合物、由其制成的药物组合物以及治疗包括癌症在内的各种疾病和失调的方法。
• CANNABIDINOID DERIVATIVES
  申请人：SUTTER WEST BAY HOSPITALS

  公开号：US20130209483A1

  公开（公告）日：2013-08-15

  The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
• RESORCINOL DERIVATIVES
  申请人：Sutter West Bay Hospitals

  公开号：US20180170846A1

  公开（公告）日：2018-06-21

  The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
• HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION
  申请人：G1 Therapeutics, Inc.

  公开号：US20200331925A1

  公开（公告）日：2020-10-22

  This invention is in the area of heterocyclic-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
• US9254272B2
  申请人：——

  公开号：US9254272B2

  公开（公告）日：2016-02-09